Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 051 778.1 |
96 | EP file number | EAKZ | 14 76 6962.6 |
86 | WO file number | WAKZ | PCT/EP2014/069425 |
97 | EP publication number | EPN | 3043816 |
87 | WO publication number | WPN | 2015036499 |
54 | Designation/title | TI | ANTI-B7-H1-ANTIKÖRPER ZUR BEHANDLUNG VON TUMOREN |
51 | IPC main class | ICM (ICMV) | A61K 39/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01), C07K 16/28 (2006.01), C07K 16/30 (2006.01) |
22 | DE application date | DAT | Sep 11, 2014 |
96 | EP application date | EAT | Sep 11, 2014 |
86 | WO application date | WAT | Sep 11, 2014 |
43 | Date of first publication | OT | Mar 19, 2015 |
| Date of publication of grant | PET | Aug 14, 2019 |
71/73 | Applicant/owner | INH | Medimmune Limited, Cambridge, Cambridgeshire, GB |
72 | Inventor | IN | NARWAL, Rajesh, Gaithersburg Maryland 20878, US; FAIRMAN, David, Cambridge Cambridgeshire CB21 6GH, GB; ROBBINS, Paul, Gaithersburg Maryland 20878, US; LIANG, Meina, Gaithersburg Maryland 20878, US; SCHNEIDER, Amy, Gaithersburg Maryland 20878, US; CHAVEZ, Carlos, Gaithersburg Maryland 20878, US; HERL, Carina, Gaithersburg Maryland 20878, US; PAK, Min, Gaithersburg Maryland 20878, US; LU, Hong, Gaithersburg Maryland 20878, US; REBELATTO, Marlon, Gaithersburg Maryland 20878, US; STEELE, Keith, Gaithersburg Maryland 20878, US; BOUTRIN, Anmarie, Gaithersburg Maryland 20878, US; SHI, Li, Gaithersburg Maryland 20878, US; HONG, Shengyan, Gaithersburg Maryland 20878, US; HIGGS, Brandon, Gaithersburg Maryland 20878, US; ROSKOS, Lorin, Gaithersburg Maryland 20878, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361876509 P Sep 11, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461971212 P Mar 27, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461978401 P Apr 11, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201462003349 P May 27, 2014
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003043816 Searchable text:
EP000003043816 Original document:
EP000003043816B1 Searchable text:
EP000003043816B1 Original document:
WO002015036499 Searchable text:
WO002015036499 |
43 | Date of first publication | EVT | Mar 19, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Sep 2, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 8, 2024 (Show all update days)(Hide all update days)- Oct 8, 2024
- St.36: changed (technical change)
- Jul 11, 2024; Jul 21, 2023; Jun 24, 2022; Aug 7, 2021; Sep 10, 2020; Aug 6, 2020; Jul 16, 2020; Sep 18, 2019; Sep 13, 2019; Aug 21, 2019; Jul 30, 2019; Jul 25, 2019; May 30, 2019; Jan 10, 2019; Sep 7, 2017
- Historical data not available for this/these date(s)
- Sep 2, 2016
- Date of the first transfer into DPMAregister
|